Standard BioTools Inc. (NASDAQ: LAB) announced it has agreed to sell its Mass Cytometry business to Multiplex Bio, a newly ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE